Cancer Theranostics is a “must have” for all scientists and engineers interested in biomedical applications of nanotechnologies, molecular imaging, or both together in particular. It is comprehensive, interdisciplinary and integrated. Theranostics is a portmanteau of therapeutics and diagnostics. Aiding researchers seeking to eliminate multi-step procedures, reduce delays in treatment, better prediction of treatment efficacy and ease patient care, Cancer Theranostics reviews, assesses and makes pertinent clinical recommendations on the integration of comprehensive in vitro diagnostics, in vivo molecular and therapeutics imaging, image-guided interventions, and nanotheranostics platforms towards the personalization and high precision of cancer treatment.

Edited by notable scientists and more than 60 leaders in the field worldwide contributing to the twenty-six chapters, this timely book covers all essential aspects of theranostics including biomarker discovery, synthesis, diagnosis, imaging, treatment, and regulation. It describes the identification of novel biomarkers to advance molecular diagnostics and therapeutics targets of cancer. It encompasses new molecular imaging probes and techniques for early detection of cancer. It describes imaging-guided and imaging-mediated cancer therapy. Discussion also includes technical platforms incorporating both novel cancer imaging and nanotechnology therapeutic components. It concludes with clinical translation, regulatory issues, and future perspectives.

Key Features

• Supports elimination of multi-step approaches and reduces delays in treatments with better prediction of treatment efficacy through combinatorial diagnosis and therapy
• Assesses cancer theranostics fully across the emergent field, with discussion varying across biomarker discovery, molecular and diagnostic imaging, imaging guided therapy, theranostics, and personalized medicine
• Content bridges laboratory, clinic, medical imaging, biotechnology and regulatory industries to advance biomedical science and improve cancer patient management

For an introduction to cancer theranostics, take a look at the first chapter from this new book.

Download (PDF, Unknown)

About the Authors

Dr. Xiaoyuan (Shawn) Chen is an expert in the fast-developing field of theranostics and cancer prognosis. He is Senior Investigator and Lab Chief at the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health.

Dr. Stephen Wong John S. Dunn Distinguished Endowed Chair of Biomedical Engineering at Houston Methodist Hospital, the Founding Chair of Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute, and a Professor of Radiology, Neurosciences, Pathology, and Laboratory Medicine at Weill Cornell Medical College.